Loading clinical trials...
Loading clinical trials...
A Prospective, Non-Intervention, Multi-Center Observational Study to Evaluate the Efficacy and Safety of CREZET Tablet in Patients With Dyslipidemia
Conditions
Interventions
Ezetimibe/Rosuvastatin
Locations
1
South Korea
Kimyounggi Clinic
Busan, South Korea
Start Date
May 24, 2023
Primary Completion Date
December 31, 2024
Completion Date
March 1, 2026
Last Updated
August 24, 2025
NCT06380322
NCT06568471
NCT05845424
NCT06322056
NCT06578676
NCT06293417
Lead Sponsor
Daewoong Pharmaceutical Co. LTD.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions